More on RNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:RNTX)
Delayed: 0.84 +0.07 (9.09%)
Prev. Close $0.77  
Open$0.79 
52 Wk High$ 
52 Wk Low$ 
Day High$0.87 
Day Low$0.79 
P/E N/A  
EPS$ 
Volume568,107 

Friends, Peers and Foes (?): ENTA WVE (more...)

Aug 27, 2026 04:05 PM Form 8-K Rein Therapeutics, Inc. For: Aug 21
Aug 20, 2026 08:00 AM FDA grants fast track status to Rein Therapeutics drug for lung fibrosis
Aug 20, 2026 08:00 AM Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
Aug 18, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Rein Therapeutics (RNTX)
Aug 14, 2026 09:32 PM Form SCHEDULE 13G Rein Therapeutics, Inc. Filed by: ADAR1 Capital Management, LLC
Aug 14, 2026 04:13 PM Form SCHEDULE 13G/A Rein Therapeutics, Inc. Filed by: Lynwood Capital Management Inc.
Aug 14, 2026 07:31 AM Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Aug 14, 2026 06:44 AM Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 06:35 AM Form 10-Q Rein Therapeutics, Inc. For: Jun 30
Aug 13, 2026 02:02 PM Form SCHEDULE 13G/A Rein Therapeutics, Inc. Filed by: LYTTON LAURENCE W
View All Articles

Entities mentioned with RNTX

View All Entities